FindTrial
Sign In

Clinical characteristics and susceptibility factors of pneumocystis carinii pneumonia in patients with connective tissue disease during immunosuppressive therapy

Clinical characteristics and susceptibility factors of pneumocystis carinii pneumonia in patients with connective tissue disease during immunosuppressive therapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100044095
Enrollment
Unknown
Registered
2021-03-11
Start date
2021-03-10
Completion date
Unknown
Last updated
2021-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumocystis carinii pneumonia associated with connective tissue disease

Interventions

PCP group:No
non-PCP group:No

Sponsors

Department of Rheumatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients who meet CTD international classification diagnostic criteria and the result of respiratory secretions (sputum) or bronchial lavage fluid tested for Pneumocystis cariniiby with PCR method is positive.

Exclusion criteria

Exclusion criteria: Patients who did not meet the CTD diagnosis or HIV patients or patients with a definite malignancy at the time of diagnosis of CTD.

Design outcomes

Primary

MeasureTime frame
the detection of sputum or alveolar lavage for pneumocystis carinii with PCR method;respiratory function;prognosis;Complication;—

Secondary

MeasureTime frame
Other laboratory tests;Sex, age, etc;—

Countries

China

Contacts

Public ContactLingli Dong

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

tjhdongll@163.com+86 27-83665519

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026